CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Denmark

In Denmark 10 Also abroad 43

10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Where
Copenhagen Oe
Age
18 years and over
People
160 worldwide
Run by
argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00
Phase 3Taking people
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Where
Copenhagen Oe
Age
18 years and over
People
218 worldwide
Run by
argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Where
Aarhus, Copenhagen
Age
18 years to 75 years
People
256 worldwide
Run by
Dianthus Therapeutics
See details and how to joinNCT06858579
Phase 3Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Where
Aarhus, Copenhagen
Age
18 years and over
People
300 worldwide
Run by
Sanofi
See details and how to joinNCT06859099 · EU 2024-517032-22-00
Phase 3Taking people
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Where
Aarhus N, Copenhagen Oe
Age
18 years and over
People
160 worldwide
Run by
Sanofi
See details and how to joinNCT06290141 · EU 2023-508338-33-00
Phase 2Taking people
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Where
Copenhagen Oe, Odense C
Age
18 years and over
People
162 worldwide
Run by
Immunovant Sciences GmbH
See details and how to joinNCT07032662 · EU 2024-517614-14-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Where
Aarhus N, Copenhagen Oe
Age
18 years and over
People
138 worldwide
Run by
Dianthus Therapeutics Inc.
See details and how to join2024-517529-26-00 · EU 2024-517529-26-00
Phase 3Taking people
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Where
Aarhus N, Copenhagen Oe
Age
18 years and over
People
59 worldwide
Run by
Takeda
See details and how to joinNCT06747351 · EU 2024-517450-95-00
No phaseTaking people
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
Where
Aarhus N, København Ø
Age
18 years and over
People
30 worldwide
Run by
Takeda
See details and how to joinNCT06538064 · EU 2024-512690-26-00
Phase 4Taking people
Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
Where
Aalborg, Aarhus N, Copenhagen Oe, Odense C
Age
18 years and over
People
60
Run by
University of Aarhus
See details and how to joinNCT04589299 · EU 2024-515898-96-01